WASHINGTON (Reuters) - Health officials said on Friday they had dropped plans to keep a public list of prescription drugs with emerging safety concerns, one of the measures proposed after Merck & Co.'s 2004 withdrawal of its arthritis drug Vioxx.Instead of a “Drug Watch” list, the Food and Drug Administration will place red asterisks next to the names of the medicines on an existing Web page that lists dozens of prescription drugs. Consumers can click on the drug name to link to FDA advisories and other information.>>> Discuss This Story
